Results
|
|
41.
|
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. [electronic resource] by
- Poon, L M
- Bassett, R
- Rondon, G
- Hamdi, A
- Qazilbash, M
- Hosing, C
- Jones, R B
- Shpall, E J
- Popat, U R
- Nieto, Y
- Worth, L L
- Cooper, L
- De Lima, M
- Champlin, R E
- Kebriaei, P
Producer: 20140506
In:
Bone marrow transplantation vol. 48
Availability: No items available.
|
|
|
42.
|
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. [electronic resource] by
- Kebriaei, Partow
- Basset, Roland
- Ledesma, C
- Ciurea, S
- Parmar, S
- Shpall, E J
- Hosing, C
- Khouri, Issa
- Qazilbash, M
- Popat, U
- Alousi, A
- Nieto, Y
- Jones, R B
- de Lima, M
- Champlin, R E
- Andersson, Borje S
Producer: 20130709
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 18
Availability: No items available.
|
|
|
43.
|
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma. [electronic resource] by
- Qazilbash, M H
- Saliba, R M
- Hosing, C
- Mendoza, F
- Qureshi, S R
- Weber, D M
- Wang, M
- Flosser, T
- Couriel, D R
- De Lima, M
- Kebriaei, P
- Popat, U
- Alousi, A M
- Champlin, R E
- Giralt, S A
Producer: 20070405
In:
Bone marrow transplantation vol. 39
Availability: No items available.
|
|
|
44.
|
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma. [electronic resource] by
- Shah, N
- Thall, P F
- Fox, P S
- Bashir, Q
- Shah, J J
- Parmar, S
- Lin, P
- Kebriaei, P
- Nieto, Y
- Popat, U R
- Hosing, C M
- Cornelison, A
- Shpall, E J
- Orlowski, R Z
- Champlin, R E
- Qazilbash, M H
Producer: 20151120
In:
Leukemia vol. 29
Availability: No items available.
|
|
|
45.
|
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. [electronic resource] by
- Ozdemir, E
- Saliba, R M
- Champlin, R E
- Couriel, D R
- Giralt, S A
- de Lima, M
- Khouri, I F
- Hosing, C
- Kornblau, S M
- Anderlini, P
- Shpall, E J
- Qazilbash, M H
- Molldrem, J J
- Chemaly, R F
- Komanduri, K V
Producer: 20070820
In:
Bone marrow transplantation vol. 40
Availability: No items available.
|
|
|
46.
|
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. [electronic resource] by
- Ciurea, S O
- Saliba, R
- Rondon, G
- Pesoa, S
- Cano, P
- Fernandez-Vina, M
- Qureshi, S
- Worth, L L
- McMannis, J
- Kebriaei, P
- Jones, R B
- Korbling, M
- Qazilbash, M
- Shpall, E J
- Giralt, S
- de Lima, M
- Champlin, R E
- Gajewski, J
Producer: 20100603
In:
Bone marrow transplantation vol. 45
Availability: No items available.
|
|
|
47.
|
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies. [electronic resource] by
- Qazilbash, M H
- Wieder, E
- Thall, P F
- Wang, X
- Rios, R
- Lu, S
- Kanodia, S
- Ruisaard, K E
- Giralt, S A
- Estey, E H
- Cortes, J
- Komanduri, K V
- Clise-Dwyer, K
- Alatrash, G
- Ma, Q
- Champlin, R E
- Molldrem, J J
Producer: 20170901
In:
Leukemia vol. 31
Availability: No items available.
|
|
|
48.
|
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. [electronic resource] by
- Foglietta, M
- Neelapu, S S
- Kwak, L W
- Jiang, Y
- Nattamai, D
- Lee, S-T
- Fowler, D H
- Sportes, C
- Gress, R E
- Steinberg, S M
- Vence, L M
- Radvanyi, L
- Dwyer, K C
- Qazilbash, M H
- Bryant, R N K
- Bishop, M R
Producer: 20131211
In:
Bone marrow transplantation vol. 48
Availability: No items available.
|
|
|
49.
|
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. [electronic resource] by
- de Lima, M
- Champlin, R E
- Thall, P F
- Wang, X
- Martin, T G
- Cook, J D
- McCormick, G
- Qazilbash, M
- Kebriaei, P
- Couriel, D
- Shpall, E J
- Khouri, I
- Anderlini, P
- Hosing, C
- Chan, K W
- Andersson, B S
- Patah, P A
- Caldera, Z
- Jabbour, E
- Giralt, S
Producer: 20080326
In:
Leukemia vol. 22
Availability: No items available.
|
|
|
50.
|
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. [electronic resource] by
- Varma, A
- Saliba, R M
- Torres, H A
- Afrough, A
- Hosing, C
- Khouri, I F
- Nieto, Y
- Shah, N D
- Parmar, S
- Bashir, Q
- Ahmed, S
- Jones, R B
- Kebriaei, P
- Olson, A L
- Shpall, E J
- Alousi, A M
- Qazilbash, M H
- Champlin, R E
- Popat, U
Producer: 20180213
In:
Bone marrow transplantation vol. 51
Availability: No items available.
|
|
|
51.
|
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas. [electronic resource] by
- Srour, S A
- Singh, H
- McCarty, J
- de Groot, E
- Huls, H
- Rondon, G
- Qazilbash, M
- Ciurea, S
- Bardelli, G
- Buck, J
- Alousi, A
- Nieto, Y
- Rezvani, K
- Marin, D
- Popat, U
- Hosing, C
- Shpall, E J
- Wierda, W G
- Kantarjian, H
- Champlin, R E
- Cooper, L J
- Kebriaei, P
Producer: 20201020
In:
Blood vol. 135
Availability: No items available.
|